Synthetic Biologics, Inc. (SYN)
SG&A Expense Growth
-2.17%
Quarterly · Period ending:
SYN SG&A Expense Growth
Latest reported-2.17%period ending
Latest reported-2.17%period ending
SYN Quarterly SG&A Growth (QoQ) (0.00% → -2.17%)
Latest values, visible window
High-resolution chart · PNG
SYN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -2.1718% | |
| 122.7957% | |
| -50.7676% | |
| -83.1022% | |
| 671.4976% | |
| -36.8902% | |
| 0% | |
| 0% | |
| -92.1102% | |
| 22.0809% | |
| -47.8065% | |
| 72.545% | |
| 62.9333% | |
| -9.3656% | |
| -33.4272% | |
| 90.7905% | |
| 3.004% | |
| -10.8527% | |
| 23.0703% | |
| -3.6759% | |
| -6.9207% | |
| -7.6813% | |
| 8.5737% | |
| 16.8488% | |
| 5.1724% | |
| -9.5321% | |
| -3.9933% | |
| -18.4532% | |
| 3.0049% | |
| -11.6667% | |
| -20.0789% | |
| 18.8856% | |
| 3.7105% | |
| -21.3397% | |
| -39.8561% | |
| 65.8711% | |
| -2.422% | |
| -11.5004% | |
| -4.2998% | |
| 58.0424% | |
| -27.8128% | |
| 29.714% | |
| -7.8537% | |
| 52.6273% | |
| -32.8556% | |
| 61.6756% | |
| -28.169% | |
| -17.3545% | |
| 50.2385% | |
| 12.1212% | |
| -13.3591% | |
| 20.6897% | |
| -8.7585% | |
| -19.891% | |
| 2,482.2274% | |
| -109.0382% | |
| -1.797% | |
| -45.484% | |
| 78.3199% | |
| 19.3387% | |
| -9.2052% | |
| -10.3774% | |
| -37.1649% | |
| 232.8458% | |
| -25.807% | |
| -20.1338% | |
| 37.1234% | |
| -28.6646% | |
| -4.2461% | |
| -36.8044% | |
| 4.6035% | |
| 59.9063% | |
| -19.9596% | |
| -50.205% | |
| 5.0459% | |
| 47,352.5025% | |
| -30.8503% | |
| -97.6315% | |
| 1,742.12% | |
| 0% | |
| 0% | |
| 0% | |
| -127.6446% | |
| 0% | |
| -100% | |
| -19.1078% | |
| -18.8756% | |
| -57.8738% | |
| -25.5811% | |
| 18.0459% | |
| 59.2051% | |
| -7.8577% | |
| 47.643% | |
| -16.7039% | |
| 74.7073% | |
| -24.6393% | |
| -0.4754% | |
| 2.5974% | |
| 35.4272% | |
| -16.6667% |